$23.89
-0.330 (-1.36%)
At Close: Jun 22, 2026
Morning Market Stats in 5 Minutes
12:00am, Thursday, 20'th Aug 2020
Movers
Indices
• S&P 500 ETF (NYSE:SPY) decreased 0.51% to $335.41.
• Nasdaq ETF (NASDAQ:QQQ) decreased 0.30% to $275.26.
• Dow Jones Industrial Average ETF (...
Charting a pulling-teeth breakout attempt: S&P 500, Nasdaq challenge record territory
04:41pm, Tuesday, 18'th Aug 2020
Technically speaking, the S&P 500 and Nasdaq Composite have registered nominal record highs this week, though a pulling-teeth breakout attempt remains...
Dr. Marijn Dekkers Joins AgBiome As a Strategic Advisor
01:00pm, Wednesday, 12'th Aug 2020
AgBiome, a leader in developing innovative products from the Earth's microbial communities, announced Dr. Marijn Dekkers as the company's newest advisor. Dr. Dekkers is the founder and chairman of Nov
Elanco Animal Health Might Just Be the Cat's Meow
07:11pm, Monday, 10'th Aug 2020
Jim Cramer on his "Mad Money" show's Lightning Round segment last Thursday discussed Elanco Animal Health Inc. . In this daily bar chart of ELAN, below, we can see a pattern of higher lows from Marc
Top Insider Buys Highlight for the Week of August 7
07:04pm, Saturday, 08'th Aug 2020
The largest Insider Buys this week were for Boeing Co., IQVIA Holdings Inc., Schlumberger Ltd. and Elanco Animal Health Inc. Continue reading...
Animal parasiticide manufacturers are primarily investing in collaborations with businesses in the veterinary industry to support research towards customized product development initiatives. DUBLIN, I
Bayer: Many Upside Catalysts But The Litigation Risks Weigh More Heavily (OTCMKTS:BAYRY)
11:08am, Thursday, 06'th Aug 2020
Bayer shares are now back in no man's land. It seems that the uncertainties surrounding the litigation risks are weighing too heavily on the share price.
The Global Animal Growth Enhancers Market will grow by USD 4.05 bn during 2020-2024
Elanco CEO on $7.6B purchase of Bayer Animal Health
01:43pm, Wednesday, 05'th Aug 2020
Elanco has closed its $7.6 billion acquisition of Bayer Animal Health. Elanco CEO Jeff Simmons joins Yahoo Finance’s Brian Sozzi and Alexis Christoforous to discuss.
The Global Animal Healthcare Market will grow by $ 7.98 bn during 2020-2024
MyoKardia Heart Trial, And Other News: The Good, Bad And Ugly Of Biopharma (NASDAQ:MYOK)
03:41pm, Tuesday, 04'th Aug 2020
MyoKardia reports initiating trial for invasive septal reduction therapy. Aileron completes enrollment in chemotherapeutic agent trial.
Henry Schein Reports Second Quarter 2020 Financial Results
12:00am, Tuesday, 04'th Aug 2020
Henry Schein, Inc. reports second quarter 2020 financial results from continuing operations.
Bayer : completes the sale of its Animal Health business unit to Elanco | MarketScreener
11:52am, Monday, 03'rd Aug 2020Elanco Closes Acquisition of Bayer Animal Health
10:00am, Monday, 03'rd Aug 2020
Elanco Animal Health Incorporated (NYSE: ELAN) today announced it has closed the acquisition of Bayer Animal Health. The transaction, valued at $6.89 billion, expands Elanco’s scale and capabilities
Sign In
Buy ELAN